Beijing Zhongshan Golden Bridge Biotechnology is Other Devices and Supplies in China that focus on Chinese oncology business. Founded in 1993. They cover business area such as Provider, pathology testing product, Beijing, China, hospital, laboratory.
1993
( 31 years old in 2024 )
Chinese Oncology
-
Xuanwu South del 23, Lihengmingyuan 2
Xuanwu District, Beijing Road, 2302 East
Beijing, 100055
China
Private
Providerpathology testing productBeijingChinahospitallaboratory
* We use standard office opening hours in near Beijing Zhongshan Golden Bridge Biotechnology's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Beijing Zhongshan Golden Bridge Biotechnology is Other Devices and Supplies business from China that founded in 1993 (31 years old in 2024), Beijing Zhongshan Golden Bridge Biotechnology business is focusing on Chinese Oncology.
Beijing Zhongshan Golden Bridge Biotechnology headquarter office and corporate office address is located in Xuanwu South del 23, Lihengmingyuan 2 Xuanwu District, Beijing Road, 2302 East Beijing, 100055 China.
Beijing Zhongshan Golden Bridge Biotechnology was founded in China.
In 2024, Beijing Zhongshan Golden Bridge Biotechnology is currently focus on Chinese oncology sector.
Above is snippet of Google Trends for "Chinese oncology" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Beijing Zhongshan Golden Bridge Biotechnology, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.